Mail & Guardian
Mail & Guardian
dtglatest news & developments
Dolutegravir was initially dubbed a wonder drug but a small possible risk of birth defects stalled a global rollout. South Africa has put strict monitoring in place to catch any potential defects early.
ANTIRETROVIRAL DRUGS

Risks & benefits: new HIV drug combo could change the course of SA’s epidemic

South Africa’s next chapter in HIV treatment holds amazing promise, but unlocking it rests on having the right kind of discussions with women

  • Laura López González
5 min read